News & Events
MS researcher Arman Eshaghi answers questions from around the world
An exciting new international fundraising campaign for MS is coming your way
Long-term follow-up studies could help determine predictive factors for long-term clinical outcomes
Study suggests that longer observation time is necessary for more reliable results
Switching from natalizumab to an alternative drug may prevent disease reactivation
Arman Eshaghi will answer your questions
Results show daclizumab to be effective in reducing relapse rate and new lesions in relapsing-remitting MS
Brazilian MS Association ABEM is taking part in a campaign to highlight the importance of mental health…
On 21st October, MS Ireland launched a report on the costs of multiple sclerosis to Irish society
There are two World Days coming up which will be of interest to the global MS community.
Which of these MS research areas would you like to hear more about?
We spoke to an Argentinian researcher studying the correlation between melatonin and MS